Pi2 Solutions introduces Drug Safety Triager application in UK

Pi2 Solutions introduces its Drug Safety Triager™ application to a wide UK audience of Drug Safety and Medical Information professionals at the 8th Annual Conference of the Pharmaceutical Information and Pharmacovigilance Association (PIPA) in Chesham, England.

Following 10 years' success with Pinpoint™, Pi2's flagship Product Literature Database system, Pi2 has introduced Drug Safety Triager™. Drug Safety Triager™ is already in use by a number of the largest pharma companies in the US and mainland Europe. "We felt that the PIPA conference, with its focussed delegation of PV and MI specialists was the ideal setting to introduce our UK colleagues to the DST application which is attracting so much attention elsewhere," said Mark Drinkwater, co-founder of Pi2. "At the same time, we have a long history with PIPA and wanted to express our appreciation of their work through our Gold level sponsorship of this event."

PIPA remarked, "We were very pleased to see Pi2 so prominently at this year's conference and to hear of their latest innovative developments."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medicaid tries new approach with sickle cell: Companies get paid only if costly gene therapies work